This Algorithm Finds Upside Dividend Surprises
When it comes to dividend growth for the rest of this year and next year, this Wall Street strategist is especially bullish – and based… Read More »This Algorithm Finds Upside Dividend Surprises
When it comes to dividend growth for the rest of this year and next year, this Wall Street strategist is especially bullish – and based… Read More »This Algorithm Finds Upside Dividend Surprises
When it comes to biotechnology and healthcare, the author of today’s article advises that “While you might think that coronavirus vaccine stocks take the cake… Read More »3 Biotech Stocks To Watch As Other Trends Take The Spotlight Away From COVID
A commercial-stage biopharmaceutical company focused on developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health and a clinical-stage biopharmaceutical company… Read More »Women’s Sexual Health, Oncology & COVID-19: 3 Biotech Penny Stocks To Watch Right Now
A company focused on creating monoclonal antibodies, a second that creates drugs targeted at treating serious and common diseases, and a third developing two drugs… Read More »3 Hot Biotech Penny Stocks To Watch As August Heats Up
While many investors are familiar with examples of smaller biotech firms delivering jaw-dropping intraday gains on the back of positive clinical trial news or FDA approvals,… Read More »This Biotech ETF’s Holdings “Are In A Sweet Spot For Takeover Activity”
The two biotech stocks highlighted in today’s article await big FDA decisions this month – one for an anti-itch drug that could be used in… Read More »Ahead Of Big FDA Decisions On Their Anti-Itch And Anti-Cancer Drugs, Analysts See These 2 Biotech Stocks As Solid Buys
A biopharma company involved in COVID-19 vaccines and an acquisition company for medical technologies comprise the two new biotech stocks to watch highlighted in today’s… Read More »New Stocks To Watch In Biotech, Tech, Cleantech & More
Shares of the two drug makers discussed in today’s article have been beaten down, thanks in large part to an FDA advisory panel vote in… Read More »Are These 2 Beaten-Down Biotechs Buys Before Bouncing Back?
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s… Read More »“Sizable Upside Potential”: 5 Low-Priced Stocks For Highly Aggressive Investors
If you want to pick your own biotech stocks, rather than investing in a biotech-focused ETF or mutual fund, the author of today’s article advises… Read More »Biotech Bargains: 4 Names Trading Far Below Their Average Price Targets